AzTrials
AzTrials

BruxismNCT07868341

Influence Of Different Relaxation Techniques On Stress Level For Patients With Bruxism Using Salivary Biomarkers.

A study testing The Rocabado Program, Jacobson Progressive Muscle Relaxation Technique and Surface electromyography biofeedback in people with Bruxism and Stress (Psychology), run by Misr University for Science and Technology at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will compare the effect of three different physical therapy techniques on stress level on patients with bruxism by assessment of morning salivary biomarkers. Read more about this study

Who is it for?
Ages 20 to 30 years
Conditions the study is for
Bruxism, Stress (Psychology)
What is being tested?
The Rocabado Program, Jacobson Progressive Muscle Relaxation Technique and Surface electromyography biofeedback
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteEgypt
Study dates
21 Sep 2026to 21 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Mild to moderate bruxism according to BRUX Scale.
  • At least one of the following conditions: a history of tooth clenching or grinding sounds during the last 6 months, pain around the temporomandibular joint causing discomfort in the morning, tenderness of masticatory muscles on palpation, masticatory muscle hypertrophy, tooth indication on the cheek mucosa and or tongue.
  • Moderate stress level ranged from 14-26 according to the perceived stress scale.

Who cannot join

  • Received any Botox, PRP (Plasma rich platelets) injection treatment for this condition for the last six months.
  • Sever cases
  • Any advanced periodontal disease as malocclusion
  • Any intra oral fixed splints
  • Pregnancy
  • Hypertension
  • Under psychiatric care
  • Parkinson's and any other neurological disease affecting the orofacial function or lead to masticatory muscles hyperactivity.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Myassar Ayman Amine, Master's degree contact

+0201229007500 ext. +02

Myassar.amine@must.edu.eg

Egypt1 site
  • Misr university for Science and Technology

    Giza, 3237101

    Myassar Ayman Amine, Master's degree, +2001229007500 ext. +20, Myassar.amine@must.edu.eg

    Myassar Ayman Amine, Master's degree

Other trials in Egypt

About this study

This study will compare the effect of three different physical therapy techniques on stress level on patients with bruxism by assessment of morning salivary biomarkers.

Read the detailed description

Objective: This study will compare the effect of Rocabado program, Jacabson progressive muscle relaxation technique and biofeedback on controlling the stress level reflected on the morning cortisol level on patients with bruxism.

Background: Bruxism is a masticatory muscle hyperactivity activity, it's not a comorbidity. Since it's a behaviour it's causes are frequently complex and multifactorial which need multidiscipline approach for assessment and treatment.

Methods: Forty five male and female patients with mild and moderate bruxism will participate in this study; they will be divided into three equal groups, group A will receive 12 sessions of Rocabado program, group B will receive 12 sessions of Jacobson progressive muscle relaxation and group C will receive 12 sessions of electromyography biofeedback. Data from three groups will be obtained pre and post treatment regarding the morning cortisol level to measure the level of the stress and to compare the effect of different physical therapy modalities in controlling the stress level in people with bruxism

Being tested
The Rocabado Program, Jacobson Progressive Muscle Relaxation Technique, Surface electromyography biofeedback
Keywords
Bruxism, Electromyography, Biofeedback, Salivary cortisol level, progressive muscle relaxation
Medical subject headings
Bruxism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Rocabado ProgramOther

    The Rocabado program include learning a new postural position, restoring original muscle length and stiffness, normal joint mobility, and body balance.

  • Jacobson Progressive Muscle Relaxation TechniqueOther

    Jacobson developed the method of progressive muscle relaxation progressive muscle relaxation method as a supportive therapy for the treatment of neurological disorders.

  • Surface electromyography biofeedbackOther

    A non invasive process by surface electrodes that using visual and auditory cues via electronic monitoring of a normally masticatory function to train bruxers to acquire voluntary control of the hyperactivity

Study groups in NCT07868341
Study groupRoleWhat they receive
group AExperimental15 Patients
Receives: Other: The Rocabado Program
BExperimental15 Patients
Receives: Other: Jacobson Progressive Muscle Relaxation Technique
CExperimental15 patients
Receives: Other: Surface electromyography biofeedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Morning salivary cortisol level

    morning salivary cortisol reflect the stress level before and after the intervention on the 3 groups

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2026
  2. Study start21 Sep 2026 (estimated)
  3. Primary completion21 Oct 2026 (estimated)
  4. Study completion21 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Forty five male and female patients with mild and moderate bruxism participated in this study; they were divided into three equal groups the mean values ± SD of patients age of groups A, B and C were 25.6 ± 3.33, 25.67 ± 3.89 and 24.93 ± 3.22 years respectively, There was no statistical significant difference between the three groups in the mean values of age (p=0.818)., group A received 12 sessions of Rocabado program, group B received 12 sessions of Jacobson progressive muscle relaxation and group C received 12 sessions of electromyography biofeedback. Data obtained from three groups pre and post treatment regarding the morning cortisol level to measure the level of the stress.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07868341
Sponsor's protocol ID
CairoUni-Bruxism-2026
Status last verified
Oct 2026
First submitted
25 Sep 2026
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Morning salivary cortisol levels before and after

Questions about this trial

What is this clinical trial studying?

A study testing The Rocabado Program, Jacobson Progressive Muscle Relaxation Technique and Surface electromyography biofeedback in people with Bruxism and Stress (Psychology), run by Misr University for Science and Technology at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Myassar Ayman Amine, Master's degree (+0201229007500 ext. +02, Myassar.amine@must.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Morning salivary cortisol level (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in